This opportunity funds translational research focused on understanding the emergence and progression of schizophrenia and related disorders during mid to late life. Research should aim to elucidate mechanisms underlying these disorders in adults over 35 and identify targets for future prevention and treatment strategies. Clinical trials are optional under this initiative.
Eligible applicants include a wide range of organizations such as public housing authorities, nonprofits, tribal governments, small businesses, educational institutions, and various government entities. Specific eligibility details should be confirmed with the funding organization.
